Delivery Order SPE2DB22D2211-SPE2DB23FNXT3

Award Date 8/8/23
Potential Completion Date 8/9/23
Potential Value $329
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $958 to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. The order is to supply 2.5mL of the glaucoma drug to a DLA facility located in Conshohocken, Pennsylvania. Amerisourcebergen will perform as the prime contractor, delivering the pharmaceutical product between July 18-19, 2023. No additional details were provided regarding subcontractors or the context of the requirement...
The Defense Logistics Agency awarded a $164,440 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. The order is being fulfilled under the prime contractor's Corporate Office Division operations in Conshohocken, Pennsylvania, with performance spanning from July 31 to August 1, 2023. As a leading supplier of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will deliver the requested ophthalmic...
The Defense Logistics Agency awarded a $493 delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. The firm fixed price order is to supply 2.5mL of the glaucoma drug to a DLA facility in Conshohocken, Pennsylvania, with performance from August 31st to September 1st, 2023. Amerisourcebergen will deliver the requested pharmaceutical product to the Defense Logistics Agency, the Department of Defense's combat logistics support agency, in support of its...
The Defense Logistics Agency awarded a $164 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. As the prime contractor, Amerisourcebergen will supply the eye medication to support DLA needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in early August 2023. No subcontractors or set aside designations were identified. This order is consistent with DLA's role to procure...
The Defense Logistics Agency awarded a $246.66 delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. The firm fixed price order is to supply 2.5mL of the solution and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania between August 16-17, 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, Amerisourcebergen routinely supports the DLA's mission to provide critical logistics...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $775 to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. The contract has a period of performance from July 24, 2023 through July 25, 2023. Amerisourcebergen will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania in support of the Defense Logistics Agency's medical supply chain responsibilities. No set aside provisions or...
The Defense Logistics Agency awarded a $479.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. As the prime contractor, Amerisourcebergen will supply the ophthalmic solution to support DLA programs from its facility in Conshohocken, Pennsylvania within the one-day period of June 26-27, 2023. The delivery order was placed against an existing DLA-wide supply contract vehicle and does not include any subcontractors. The award provides a...
The Defense Logistics Agency awarded a $239,850 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. The prime contractor will deliver 2.5ml bottles of the glaucoma medication to the DLA under this single day contract ending June 23, 2023. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were specified. The DLA manages the Department of Defense's global...
The Defense Logistics Agency awarded a $575.54 delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. The firm fixed price order is being fulfilled under the Prime Vendor Program contract vehicle and calls for the delivery of 2.5ml bottles of the glaucoma drug to a facility in Conshohocken, Pennsylvania. Performance will take place between August 18-21, 2023. No subcontractors or set aside designations were specified. The order supports the DLA's medical...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $239.85 to Amerisourcebergen Drug Corporation for the supply of RHOPRESSA 0.02% ophthalmic solution. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements under the contract. No major subcontractors or set aside designations were indicated. The delivery order was issued against an...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB23FNXT3
    Delivery Order

The Defense Logistics Agency awarded a $328.88 delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. As the prime contractor, Amerisourcebergen will supply 2.5mL bottles of the glaucoma medication to support DLA programs. The firm fixed price order is for performance from August 8-9, 2023 at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. This award draws from DLA's pharmaceutical contracts to provide needed medications and supports the Agency's mission to deliver medical supplies to military treatment facilities worldwide.

Generated 12/14/23, 10:41 PM